Choosing the Right Valuation Approach for Your Startup

Choosing the Right Valuation Approach for Your Startup

The right valuation method for your startup depends on three things: your revenue stage, the purpose of the valuation — fundraising, ESOP pricing, tax filing, or acquisition — and the regulatory framework governing your specific transaction. A pre-revenue startup cannot credibly use a DCF model; a profitable company that leans solely on the Berkus method will lose credibility with any serious diligence counsel. Match method to moment, triangulate across at least two valuation families, and always engage a qualified valuer for statutory work.

Why Method Is the Argument, Not the Number

Every investor, acquirer, or tax officer who scrutinises your valuation is really scrutinising your method. The number is just the conclusion of the argument. A defensible valuation report answers five questions before any number is presented: Which method did you choose? Why is it appropriate for this stage and sector? What inputs did you use? How sensitive is the output to those inputs? And who performed the analysis?

A wrong method produces a fragile number. Consider a D2C beauty brand at Rs. 3 crore revenue, no EBITDA, valued using a pure DCF with a 25% terminal growth rate. That number will not survive a single round of serious negotiation — because the model's output is entirely a function of two heroic assumptions (growth and discount rate) rather than observable market evidence. Contrast that with the same brand valued at 3–4x EV/Revenue on the basis of three comparable acquisitions in the Indian D2C space in the last 18 months: that number has an anchor in reality, and the investor knows it.

The discipline of method selection is, in effect, the discipline of intellectual honesty about what you actually know — and what you are estimating.

The Three Valuation Families

Valuation methodology divides into three families. Understanding what each one actually measures tells you immediately which is appropriate.

Income Approach

The income approach values what the business will earn in the future and discounts those earnings back to today. The two main tools are:

• Discounted Cash Flow (DCF): Project free cash flows over a 5–10 year explicit period, then capitalise a terminal value, and discount everything at the Weighted Average Cost of Capital (WACC). For Indian growth-stage startups in FY 2026-27, WACC benchmarks typically land between 18% and 28% depending on stage, sector, and leverage — considerably higher than US comps because of the equity risk premium and illiquidity adjustment.
• Capitalisation of Earnings: Suitable for stable, mature businesses. Divide maintainable earnings by a capitalisation rate. Almost never appropriate for early-stage startups where earnings are negative or highly volatile.

DCF is powerful when you have 18+ months of operating history that lets you build a credible base-year model. Applied to a 6-month-old company with Rs. 20 lakh in revenue and three assumed inflection points, it is a precision instrument pointed at fog.

Market Approach

The market approach values by reference to what comparable businesses are actually selling for in the market today. Its two tools are:

• Comparable Company Multiples (EV/Revenue, EV/ARR, EV/EBITDA): Identify a peer set of listed or recently funded companies, extract their trading or deal multiples, and apply those multiples — adjusted for size, growth, and margin — to your own metrics.
• Precedent Transactions: Look at actual M&A or secondary sale prices for comparable private companies. More directly relevant than listed peers but harder to source in India, where deal disclosures remain thin outside SEBI-mandated filings.

For Indian B2B SaaS, EV/ARR multiples corrected sharply from 10–15x in 2021 to 4–7x by 2024 and have stabilised in the 4–8x range in FY 2025-26, with the upper end commanded by companies showing greater than 100% Net Revenue Retention and gross margins above 70%.

Cost Approach

The cost approach asks: what would it cost to recreate this asset? Its tools are Net Asset Value (NAV) and replacement cost. This approach is most relevant for asset-heavy businesses (real estate, manufacturing), distressed situations, or holding companies. For a software startup, the "replacement cost" of code is theoretically low — a motivated team could rebuild it — so cost approach almost always produces a floor, not a fair value. Use it for early-stage IP-light startups only to establish a minimum baseline, never as a standalone.

Stage-by-Stage Method Selection

The right method is almost always obvious once you identify where you actually are.

Pre-Revenue / Ideation (Zero to Rs. 10 Lakh MRR)

At this stage, you have no operating history and no meaningful revenue to anchor a multiple. The methods that work are:

• Berkus Method: Assigns a value (typically Rs. 1–2 crore per factor in India) to five risk-reduction milestones — sound idea, working prototype, quality management team, strategic relationships, product rollout or sales. Maximum pre-money value: Rs. 8–10 crore. Transparent and fast, but entirely qualitative.
• Scorecard Method: Compares the startup against an average pre-seed/seed deal in the same geography and sector, then adjusts up or down for strength of team, market size, product, competition, and execution risk.
• Risk Factor Summation: Systematically adds or subtracts from a median value based on twelve categories of risk (management, political, funding, litigation, technology, etc.). Each positive factor adds Rs. 25–50 lakh; each negative subtracts the same.

None of these are statutory methods. They are negotiation frameworks. Do not use them in a Rule 11UA report.

Early Revenue — Seed to Pre-Series A (Rs. 10 Lakh to Rs. 1 Crore MRR)

Now you have data — growth rate, gross margin, customer count, NRR — but not enough history for a reliable long-range forecast. Use:

• Venture Capital Method: Work backwards from an exit assumption. If comparable SaaS companies in India are acquired at 5x ARR and your projected ARR at year 5 is Rs. 80 crore, the exit value is Rs. 400 crore. Discount that to today at the target IRR (typically 30–40% for early-stage Indian VC). This is explicitly investor-logic, not auditor-logic — but it produces a number both sides can reason from.
• Revenue Multiples (modest, early-stage): Apply a discount to the prevailing market multiple to reflect lower scale, higher concentration risk, and shorter track record.

Growth Stage — Series A to Series C

This is where market approach dominates because you have enough operating data to benchmark credibly.

• EV/ARR or EV/Revenue is the primary tool for SaaS. Identify 6–10 Indian or Asia-Pacific peer companies at comparable growth rates and gross margins. Adjust the multiple for your NRR, growth rate delta, and burn multiple.
• EV/GMV or EV/Take-Rate for marketplace models.
• EV/Contribution Margin for D2C or quick-commerce where revenue recognition is gross but economics are net.

Triangulate with a DCF using conservative assumptions, primarily to check that the market-derived number is not wildly inconsistent with a reasonable long-run economics story.

Profitable Scale

Once EBITDA is positive and sustainable, income approach takes priority:

• DCF on a 5-year explicit forecast, with a terminal value calculated as EBITDA at year 5 × an exit multiple or using the Gordon Growth Model.
• EV/EBITDA multiples from listed peers or precedent transactions.

For profitable Indian tech businesses in FY 2026-27, EV/EBITDA multiples range from 15x to 30x depending on growth rate — higher for companies compounding EBITDA at 40%+ year-on-year, lower for mature, slow-growth businesses.

India's Regulatory Valuation Framework: What You Cannot Choose

Some valuation decisions are not yours to make. The following contexts mandate specific methods or qualified professionals.

Rule 11UA — Section 56(2)(viib) of the Income-tax Act, 1961

When a closely held Indian company issues shares to a resident at a price exceeding fair market value (FMV), the excess is taxable in the hands of the issuing company as income from other sources under Section 56(2)(viib). FMV must be determined using the prescribed Rule 11UA methodology: either the net asset value (book value) method or the DCF method, at the option of the company. The report must be prepared by a SEBI-registered Category I Merchant Banker.

DPIIT-recognised startups can claim exemption from Section 56(2)(viib) subject to compliance with conditions as notified — but the exemption must be actively applied for and maintained. Do not assume it applies automatically.

Practical implication: If your startup is not DPIIT-registered and you raise a round at a significant premium to NAV from a resident investor without a compliant Rule 11UA report, the premium is taxable income to your company in AY 2027-28, at the prevailing corporate tax rate. This is not a theoretical risk — it shows up in assessments.

FEMA — Cross-Border Share Transactions

Under the Foreign Exchange Management Act 1999 and the FDI policy, shares issued to non-residents in the automatic route must be priced not less than fair value arrived at using any internationally accepted pricing methodology — in practice, DCF or a comparable companies analysis. Optionally convertible instruments (OCDs, CCDs) must be priced consistently at issuance and conversion. The pricing certificate is filed with the authorised dealer bank as part of the FC-GPR filing.

For FY 2026-27, delays in FC-GPR filing beyond 30 days of allotment attract a compounding application under FEMA. Ensure the valuation report date precedes the allotment date.

Ind AS 113 — Fair Value for Financial Reporting

Companies preparing financial statements under Ind AS (mandatory for certain classes of companies under the Companies Act 2013) must measure and disclose fair values in accordance with Ind AS 113. This is a three-tier hierarchy: Level 1 (quoted prices), Level 2 (observable inputs), Level 3 (unobservable inputs — i.e., models). Most startup equity investments sit at Level 3. The standard requires disclosure of the valuation technique, significant unobservable inputs, and sensitivity analysis.

IBBI Registered Valuers

Under Section 247 of the Companies Act 2013, certain valuations — including share valuations for swap-based mergers, NCLT proceedings, and ESOPs — must be conducted by a Registered Valuer on the panel of the Insolvency and Bankruptcy Board of India (IBBI). IBBI Registered Valuers hold a recognised professional qualification (CA, CMA, CS, or engineer depending on asset class) and must be registered with a Registered Valuers Organisation (RVO) recognised by IBBI.

Do not conflate IBBI Registered Valuers with SEBI-registered Merchant Bankers — they are different categories with different scopes of authority. A common error is using an IBBI Registered Valuer's report for a Rule 11UA filing (which requires a Merchant Banker) or using a Merchant Banker's report for an NCLT-driven share exchange (which requires a Registered Valuer under the Companies Act).

Worked Example — Series B B2B SaaS, FY 2026-27

Business profile: HR-tech SaaS company, ARR of Rs. 24 crore, growing at 65% YoY, NRR of 118%, gross margin of 74%, EBITDA negative (burn multiple of 1.8x), 3 years of operating history.

Step 1 — Market Approach (EV/ARR)

Peer set: four Indian B2B SaaS companies at comparable growth rates, NRR, and gross margin. Median EV/ARR multiple of the peer set: 6.2x. Apply a 15% size discount (scale below Rs. 50 crore ARR) and a 10% premium for above-median NRR.

Adjusted multiple: 6.2x × 0.85 × 1.10 = 5.8x

Enterprise Value = Rs. 24 crore × 5.8 = Rs. 139.2 crore

Add cash (Rs. 8 crore), subtract financial debt (Rs. 0):

Equity Value (Market Approach) = Rs. 147.2 crore

Step 2 — Income Approach (DCF)

Terminal Value (year 5 FCF capitalised at WACC less 5% long-run growth): Rs. 21.7 crore ÷ (0.22 – 0.05) = Rs. 127.6 crore

Discount all cash flows at WACC of 22%. PV of explicit period FCFs ≈ Rs. –4.2 crore. PV of Terminal Value ≈ Rs. 47.1 crore.

Enterprise Value (DCF) = Rs. 42.9 crore (negative near-term drag is significant)

Add net cash Rs. 8 crore: Equity Value (DCF) = Rs. 50.9 crore

Step 3 — Triangulation

Market approach produces Rs. 147 crore; DCF produces Rs. 51 crore. The wide gap is entirely expected at this stage — DCF penalises current losses heavily, while the market approach prices in the growth story. A credible report acknowledges the gap, explains it (investor-funded growth period), and concludes a fair value range of Rs. 110–150 crore on the basis that comparable investor behaviour in the market is the dominant signal at Series B, with the DCF serving as a downside sanity check.

The founder who presents only the market number without acknowledging the DCF result will face sharp pushback in diligence. The founder who presents both — and explains the reasoning — demonstrates analytical rigour.

Operating Metrics That Move the Multiple

Within any given multiple range, your operating metrics determine where you land. For SaaS valuations in FY 2026-27:

• Net Revenue Retention (NRR): Every 10-point improvement above 100% typically justifies a 0.5–1.0x expansion in EV/ARR multiple. NRR of 120%+ is a material premium signal.
• Gross Margin: B2B SaaS above 70% gross margin trades at a premium to infrastructure-heavy or services-mixed businesses at 50–55%.
• Burn Multiple (net cash burned ÷ net new ARR): Below 1.0x is exceptional; 1.0–1.5x is healthy; above 2.0x is a discount trigger.
• Rule of 40 (revenue growth % + EBITDA margin %): 40+ at scale commands premium EV/EBITDA. Below 20 at Series B is a flag.
• CAC Payback Period: For D2C, under 12 months is strong. Over 24 months suggests structural unit economics risk that discounts both revenue multiple and DCF assumptions.

These metrics are not decorative — they are the inputs that justify where you position yourself within the peer range. Build your data room around them before you commission the valuation.

Triangulation: Why One Method Is Never Enough

Any single method has blind spots. DCF is sensitive to terminal growth rate and WACC — a 2% change in WACC on a Rs. 200 crore terminal value can swing equity value by Rs. 30–40 crore. Comparable company multiples depend on peer selection, and a careless peer set (including a single outlier with a strategic acquirer premium) distorts the entire analysis. Precedent transactions may be stale — a deal done in Q2 FY 2024 at 8x ARR may not be relevant in Q1 FY 2027.

The discipline of triangulation forces you to explain why different methods converge or diverge — and that explanation is itself a form of intellectual due diligence. A one-method report is a red flag in a sophisticated investor's diligence checklist.

Common Mistakes and Pitfalls to Avoid

• Using DCF for a pre-revenue startup. The model has no base; every output is an assumption of an assumption. It creates an illusion of precision with zero reliability.
• Building a peer set from name recognition, not financial comparability. Including Freshworks in a peer set for a 50-person SaaS company inflates your multiple and destroys credibility.
• Confusing enterprise value and equity value. If your company has Rs. 15 crore in preference shares outstanding (which rank ahead of equity on liquidation), your equity value is not your enterprise value. This error is more common than it should be.
• Loading an ESOP top-up into pre-money and ignoring the dilution. If you are creating a 10% ESOP pool pre-money before the round closes, that dilution is borne by founders. Running the cap table without accounting for it overstates the effective pre-money for existing shareholders.
• Using an unregistered or wrong-category valuer for a statutory filing. An IBBI Registered Valuer report will not satisfy a Rule 11UA query. A CA's internal valuation memo will not satisfy an FC-GPR filing. Match the credential to the purpose.
• Anchoring the valuation date wrong. The valuation must be as at a date proximate to the transaction. A report dated 8 months before allotment is stale for FEMA purposes and may be rejected by the AD bank.
• Ignoring sensitivity analysis. A valuation without a sensitivity table (varying the two or three most impactful assumptions) is a conclusion dressed as analysis. Investors and tax officers alike will test your assumptions — present the range before they do.

Key Takeaways

• Stage determines method: Berkus and scorecard for pre-revenue; VC method and revenue multiples for early-revenue; EV/ARR or EV/EBITDA at growth stage; DCF at profitable scale.
• Regulatory purpose determines credential: Rule 11UA demands a SEBI-registered Category I Merchant Banker; Companies Act valuations (mergers, ESOPs under certain structures) demand an IBBI Registered Valuer; FEMA requires a report based on an internationally accepted methodology prepared proximate to the transaction date.
• Always triangulate: Use at least two methods. Explain convergence or divergence in the report. One-method reports invite challenge.
• Operating metrics are the proof: NRR, gross margin, burn multiple, and Rule of 40 are the inputs that justify your position within a peer multiple range — not just the multiple itself.
• The valuation date matters legally: For FEMA, the report must predate allotment. For Rule 11UA, it must be contemporaneous with the issuance. Backdated or stale reports create compounding and assessment risk.
• Angel tax is a live risk for non-exempt companies: If your startup is not DPIIT-recognised and conditions for exemption are not met, a Rule 11UA-compliant FMV report is not optional — it is the difference between a clean balance sheet and a tax demand in AY 2027-28.
• Method is the argument; number is the conclusion: Defend the method, and the number follows. Defend only the number, and you have nothing left when challenged.